The difficulty of improving the treatment of Alzheimer’s disease has become clear

Vaccitech is trialling what it hopes will be a more effective, universal flu vaccine

A new tool tests the likelihood that a drug will undergo racemisation

Growth drugs hold huge potential for various unmet clinical needs

New technology can screen many more antibodies than existing methods

Life sciences firms need to adapt how they approach data management

The industry is undergoing dramatic change as new tech brings disruption